Claudio Catalani

498 total citations
25 papers, 442 citations indexed

About

Claudio Catalani is a scholar working on Genetics, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Claudio Catalani has authored 25 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 12 papers in Molecular Biology and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Claudio Catalani's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (15 papers), Receptor Mechanisms and Signaling (10 papers) and Blood Coagulation and Thrombosis Mechanisms (9 papers). Claudio Catalani is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (15 papers), Receptor Mechanisms and Signaling (10 papers) and Blood Coagulation and Thrombosis Mechanisms (9 papers). Claudio Catalani collaborates with scholars based in Italy, Spain and Japan. Claudio Catalani's co-authors include Stefania Meini, Paola Cucchi, Francesca Bellucci, Sandro Giuliani, Carlo Alberto Maggi, Laura Quartara, Alessandro Giolitti, Alessandro Lecci, Riccardo Patacchini and Manuela Tramontana and has published in prestigious journals such as PLoS ONE, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Claudio Catalani

24 papers receiving 437 citations

Peers

Claudio Catalani
Tomiaki Asai Japan
Stéphanie Delaire France
Rosaria Leante Italy
Paola Origone Italy
Katrina A. Marsh United Kingdom
Yujun Pan China
Alessandra Minasi Italy
Antonio Guerrero Spain
Verena I. Leussink Germany
Debra Mitchell Canada
Tomiaki Asai Japan
Claudio Catalani
Citations per year, relative to Claudio Catalani Claudio Catalani (= 1×) peers Tomiaki Asai

Countries citing papers authored by Claudio Catalani

Since Specialization
Citations

This map shows the geographic impact of Claudio Catalani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Catalani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Catalani more than expected).

Fields of papers citing papers by Claudio Catalani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Catalani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Catalani. The network helps show where Claudio Catalani may publish in the future.

Co-authorship network of co-authors of Claudio Catalani

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Catalani. A scholar is included among the top collaborators of Claudio Catalani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Catalani. Claudio Catalani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Santicioli, Paolo, Stefania Meini, Sandro Giuliani, et al.. (2013). Characterization of ibodutant at NK2 receptor in human colon. European Journal of Pharmacology. 702(1-3). 32–37. 6 indexed citations
3.
Meini, Stefania, Paola Cucchi, Laura Tinti, et al.. (2012). Fasitibant prevents the bradykinin and interleukin 1β synergism on prostaglandin E2 release and cyclooxygenase 2 expression in human fibroblast-like synoviocytes. Naunyn-Schmiedeberg s Archives of Pharmacology. 385(8). 777–786. 9 indexed citations
4.
Meini, Stefania, et al.. (2010). Bradykinin and B2 receptor antagonism in rat and human articular chondrocytes. British Journal of Pharmacology. 162(3). 611–622. 27 indexed citations
5.
Meini, Stefania, Paola Cucchi, Claudio Catalani, et al.. (2010). Radioligand binding characterization of the bradykinin B2 receptor in the rabbit and pig ileal smooth muscle. European Journal of Pharmacology. 635(1-3). 34–39. 6 indexed citations
6.
Meini, Stefania, Francesca Bellucci, Claudio Catalani, et al.. (2010). Comparison of the molecular interactions of two antagonists, MEN16132 or icatibant, at the human kinin B2receptor. British Journal of Pharmacology. 162(5). 1202–1212. 10 indexed citations
7.
Meini, Stefania, Paola Cucchi, Claudio Catalani, et al.. (2009). Pharmacological characterization of the bradykinin B2 receptor antagonist MEN16132 in rat in vitro bioassays. European Journal of Pharmacology. 615(1-3). 10–16. 10 indexed citations
8.
Bellucci, Francesca, et al.. (2009). Novel effects mediated by bradykinin and pharmacological characterization of bradykinin B2receptor antagonism in human synovial fibroblasts. British Journal of Pharmacology. 158(8). 1996–2004. 23 indexed citations
9.
10.
Tramontana, Manuela, Riccardo Patacchini, Alessandro Lecci, et al.. (2006). MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist. European Journal of Pharmacology. 549(1-3). 140–148. 27 indexed citations
11.
Meini, Stefania, Paola Cucchi, Francesca Bellucci, et al.. (2006). Comparative antagonist pharmacology at the native mouse bradykinin B2receptor: radioligand binding and smooth muscle contractility studies. British Journal of Pharmacology. 150(3). 313–320. 11 indexed citations
12.
Meini, Stefania, Claudio Catalani, Francesca Bellucci, et al.. (2005). Pharmacology of an original and selective nonpeptide antagonist ligand for the human tachykinin NK2 receptor. European Journal of Pharmacology. 516(2). 104–111. 4 indexed citations
13.
Cucchi, Paola, Stefania Meini, Alessandro Bressan, et al.. (2005). MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization. European Journal of Pharmacology. 528(1-3). 7–16. 32 indexed citations
14.
Bellucci, Francesca, Stefania Meini, Rose‐Marie Catalioto, et al.. (2004). Pharmacological evaluation of α and β human tachykinin NK2 receptor splice variants expressed in CHO cells. European Journal of Pharmacology. 499(3). 229–238. 13 indexed citations
15.
Bellucci, Francesca, Stefania Meini, Paola Cucchi, et al.. (2004). The N-terminal of Icatibant and bradykinin interact with the same Asp residues in the human B2 receptor. European Journal of Pharmacology. 491(2-3). 121–125. 11 indexed citations
16.
Meini, Stefania, Francesca Bellucci, Claudio Catalani, et al.. (2004). Mutagenesis at the human tachykinin NK2 receptor to define the binding site of a novel class of antagonists. European Journal of Pharmacology. 488(1-3). 61–69. 15 indexed citations
17.
Meini, Stefania, Paola Cucchi, Francesca Bellucci, et al.. (2003). Site-directed mutagenesis at the human B2 receptor and molecular modelling to define the pharmacophore of non-peptide bradykinin receptor antagonists. Biochemical Pharmacology. 67(4). 601–609. 26 indexed citations
18.
Bellucci, Francesca, Stefania Meini, Paola Cucchi, et al.. (2003). A different molecular interaction of bradykinin and the synthetic agonist FR190997 with the human B2 receptor: evidence from mutational analysis. British Journal of Pharmacology. 140(3). 500–506. 14 indexed citations
19.
Carbone, Antonio, et al.. (2003). The effect of GABApentin on neurogenic detrusor overactivity, a pilot study. European Urology Supplements. 2(1). 141–141. 9 indexed citations
20.
Bellucci, Francesca, Claudio Catalani, Paola Cucchi, et al.. (2002). Pharmacological profile of the novel mammalian tachykinin, hemokinin 1. British Journal of Pharmacology. 135(1). 266–274. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomiaki Asai Breakdown of academic impact, for papers by Stéphanie Delaire Breakdown of academic impact, for papers by Rosaria Leante Breakdown of academic impact, for papers by Paola Origone Breakdown of academic impact, for papers by Katrina A. Marsh Breakdown of academic impact, for papers by Yujun Pan Breakdown of academic impact, for papers by Alessandra Minasi Breakdown of academic impact, for papers by Antonio Guerrero Breakdown of academic impact, for papers by Verena I. Leussink Breakdown of academic impact, for papers by Debra Mitchell
Rankless by CCL
2026